Astrana Health (ASTH) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Astrana Health (ASTH) is Neutral.

The composite score behind that read is -0.06, weighing +0.15 of bullish evidence against -0.29 bearish.

Astrana Health last closed at $37.55, +4.68% on the session.

Against the IVW growth benchmark the position is +3.88% over the forecast window.

The read is built from 11 underlying insights — 2 bullish and 9 bearish.

Agreement across those insights is 82%.

16 graded predictions for ASTH so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Astrana Health in the 17th percentile on valuation and the 49th percentile on return on equity, where 100 is best.

Astrana Health is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $1.78B.

StockMap tracks Astrana Health as the 47th largest of the 85 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 81 Neutral and 4 Moderate Underperform.

On that composite Astrana Health ranks 59th of 85 in the group, against a group median of +0.00.